Skip to content

Use of Human Samples from the T1D Exchange Biobank

Deadlines are 5:00 PM (Eastern). No extensions will be granted.

Milestone Date Status
Letter of Intent Required Oct 30, 2020 Passed
Application Oct 30, 2020 Passed
Award Notification Dec 01, 2020 Passed
Earliest Start Feb 01, 2021 Passed

Background & Purpose

Please click on the “RFA Announcement” link for complete information.


The T1D (Type 1 Diabetes) Exchange Biobank, or “Biobank”, is a collection of thousands of stored samples from participants in various T1D Exchange (T1DX) clinical studies. The Biobank was created to aid investigators doing T1D research by distributing biosamples collected from people with T1D to the research community. In 2020, the Biobank was transferred from the T1D Exchange to the University of Florida (UF) Diabetes Institute through funding from JDRF with the original mission of the Biobank— to aid T1D research— unchanged. The purpose of this RFA is to solicit letters of intent (LOIs) from the T1D research community to obtain Biobank samples for use in research.